(Circulation. 2000;101:2200.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From the Department of Pharmacology, Georgetown University (F.B., A.K., R.L.W., M.R.F.), and the Cardiology Division, Veterans Affairs Medical Center (M.R.F.), Washington, DC.
Correspondence to Michael R. Franz, MD, PhD, Cardiology Division, VAMC, 50 Irving St NW, Washington, DC 20422. E-mail mfranz{at}washington.va.gov
| Abstract |
|---|
|
|
|---|
Methods and ResultsIn 16 isolated Langendorff-perfused rabbit hearts, the interatrial septum was perforated to equalize biatrial pressures. Caval and pulmonary veins were occluded. Intra-atrial pressure (IAP) was increased in steps of 2 to 3 cm H2O by increasing the pulmonary outflow fluid column. Vulnerability to AF was evaluated by 15-second burst pacing at each IAP level. At baseline, IAP needed to be raised to 8.8±0.2 cm H2O (mean±SEM) to induce AF. A dose-dependent decrease in AF vulnerability was observed after Gd3+ 12.5, 25, and 50 µmol/L was added. AF threshold increased to 19.0±0.5 cm H2O with Gd3+ 50 µmol/L (P<0.001 versus baseline). Spontaneous runs of AF occurred in 5 hearts on a rise of IAP to 13.8±3.3 cm H2O at baseline but never during Gd3+. Atrial effective refractory period shortened progressively from 78±3 ms at 0.5 cm H2O to 52±3 ms at 20 cm H2O (P<0.05). Gd3+ 50 µmol/L had no significant effect on effective refractory period.
ConclusionsAcute atrial stretch significantly enhances the vulnerability to AF. Gd3+ reduces the stretch-induced vulnerability to AF in a dose-dependent manner. Block of SAC might represent a novel antiarrhythmic approach to AF under conditions of elevated atrial pressure or volume.
Key Words: stretch channels fibrillation gadolinium mechanics
| Introduction |
|---|
|
|
|---|
Stretch-activated ion channels (SACs) have been found in cardiac tissue of various species, including humans,11 12 13 and have been shown to produce potentially arrhythmogenic electrophysiological changes. Nonselective SACs pass Ca2+ as well as Na+ and K+, whereas others selectively carry K+ or Cl-.11 12 Experimental evidence indicates that SACs play an important role in promoting arrhythmias during stretch. Gadolinium (Gd3+), a potent blocker of SACs, suppressed the occurrence of stretch-induced depolarizations in ventricular myocardium6 and atrial tissue.14 The influence of SAC blockade on the intact atrium and on the propensity toward stretch-induced AF has not been explored. The aim of the present study was to evaluate in an isolated heart model whether the SAC blocker Gd3+ influences the inducibility and maintenance of AF during acute stretch. Because calcium channel block has been reported with Gd3+,15 additional experiments were performed with the L-type calcium channel blocker verapamil to rule out nonspecific AF suppression.
| Methods |
|---|
|
|
|---|
To apply graded stretch to the atria, the heart was prepared according to a model previously described.8 Briefly, the caval and pulmonary veins were ligated. A Y-shaped manometer was inserted into the superior caval vein and a pulmonary vein to measure biatrial pressure. The interatrial septum was perforated to ensure pressure equilibration between left and right atria. Perfusion fluid left the heart exclusively through a cannula in the pulmonary artery. Atrial pressure and degree of atrial dilatation were controlled by adjustment of the height of the pulmonary outflow cannula. To avoid atrial pressure changes caused by ventricular contractions, ventricular fibrillation was induced by burst pacing through a bipolar hook electrode attached to the left ventricle. The AV node was crushed to prevent retrograde atrial activation.
Electrophysiological Measurements
Endocardial electrograms were recorded from the right and
left midatrial free wall by bipolar 4F catheters introduced through the
orifice of the inferior caval vein and a pulmonary
vein. Signals were amplified by a differential DC-coupled preamplifier
(model 1009, EP Technologies) and displayed and stored on a computer
with custom data acquisition and analysis based on LabView
software (National Instruments). To test the inducibility of AF, burst
pacing was performed through bipolar epicardial hook electrodes
attached to both atrial appendages. Stimuli of 1-ms pulse duration and
3-fold diastolic pacing threshold were applied for 15
seconds at 50 Hz.
Experimental Protocol
Intra-atrial pressure was increased progressively from 0
cm H2O in steps of 2 to 3
cm H2O. Hearts were allowed to adapt to each new
pressure level for 2 minutes before a burst pacing sequence was
delivered. AF was defined as inducible when a fast irregular rhythm was
maintained >2 seconds after cessation of burst pacing. The ability of
the atria to develop sustained AF was analyzed separately.
Sustained AF was defined as a fast irregular rhythm that lasted for
>60 seconds after cessation of burst pacing and could be terminated
only by pressure lowering. The pressure level was increased until
sustained AF was induced or a pressure level of 30
cm H2O was reached.
Drug Interventions
The dose-dependence of Gd3+ effects on AF
inducibility was studied in 6 hearts. Gd3+ was
added to the perfusate in serial concentrations of 12.5, 25,
and 50 µmol/L, allowing 15 minutes for equilibration. The AF
response to burst stimulation with increasing atrial pressure was
assessed at each concentration and after a 20-minute washout
period.
The effect of Gd3+ 50 µmol/L was investigated in a total of 16 experiments. The probability of AF induction and the duration of AF were determined at each pressure step before and after application of Gd3+.
Because Gd3+ has been reported to block calcium channels and to determine whether calcium channel block could interfere with AF vulnerability during stretch, the effect of calcium channel blockade with verapamil was examined in 5 studies. Measurements were obtained before and 15 minutes after administration of verapamil 1 µmol/L. After a 20-minute washout period, Gd3+ 50 µmol/L was applied to compare the effects of both substances. In isolated hearts, verapamil 1 µmol/L achieved marked block of Ca2+ channels6 16 that could be expected to exceed the Ca2+ channel blocking effect reported with Gd3+ doses up to 80 µmol/L.14 17
The effect of SAC blockade on atrial refractoriness was evaluated in 8 hearts. The free right atrial midwall was paced in close proximity to the recording electrode at twice diastolic threshold strength. After a 10-beat train at 250-ms basic cycle length, a premature stimulus was introduced during electrical diastole. The coupling interval was shortened in 1-ms decrements until it failed to induce a propagated response, defining the ERP. Measurements were performed at increasing atrial pressure levels during baseline and after a 15-minute period of perfusion with Gd3+ 50 µmol/L. Again, atria were given 2 minutes to adapt to each pressure level before ERP determination.
Data Analysis
Data are presented as mean±SEM unless indicated
otherwise. The probability of AF induction at different atrial
pressures was analyzed by logistic regression analysis
applying the function
y=1/{1+exp[-(x-a)/b]}, where a and b are
fitting parameters determined by an iterative procedure
with a convergence criterion of a change of <0.01% for the 2
parameters. A dose-response relationship was calculated for
atrial pressures associated with 50% AF inducibility
(P50). P50 values for
different drug concentrations were compared by t test. AF
durations and ERPs at different degrees of atrial dilatation were
statistically evaluated with the paired t test. Values of
P<0.05 defined statistical significance.
| Results |
|---|
|
|
|---|
|
|
|
|
Effect of Gd3+ on AF Inducibility
In 6 hearts exposed to successive doses of 12.5, 25, and 50
µmol/L Gd3+, the vulnerability to AF was
progressively decreased (Figure 5A
).
P50 showed a linear correlation
(r=0.99; P<0.005) with
Gd3+ concentration over the 0 to 50 µmol/L
dose range (Figure 5B
). P50 increased by
0.15 cm H2O per 1 µmol/L
Gd3+. P50 differed
significantly between baseline and data at increasing
Gd3+ doses as well as among doses
(P<0.01). Each experiment lasted
3 hours. Yet
time-related changes in the preparation could not have accounted for
the observed reduction in AF vulnerability, because the effect of
Gd3+ was largely reversible after 20 minutes of
washout (P<0.01 compared with Gd3+ 25
and 50 µmol/L).
|
Gd3+ 50 µmol/L was applied to all 16
hearts. In each preparation, the lowest atrial pressure that had
enabled AF induction during baseline was no longer sufficient to
maintain AF during Gd3+. Instead, intra-atrial
pressure had to be increased to significantly higher levels to obtain
AF. P50 for AF induction was shifted from
8.8±0.2 to 19.0±0.5 cm H2O
(P<0.001). Figure 2
illustrates the pressure-related
decrease in AF inducibility. On average, atrial pressure needed to be
elevated to 21.9±0.4 cm H2O to obtain sustained
AF after Gd3+ (versus 11.6±0.6
cm H2O at baseline; P<0.001).
Gd3+ 50 µmol/L markedly decreased the
average duration of induced AF at pressures between 7.5 and 22.5
cm H2O (P<0.05; Figure 3
).
Reduced inducibility of AF was not explained by changes in pacing
thresholds (0.20±0.02 mA at baseline versus 0.21±0.02 mA with
Gd3+ 50 µmol/L; P=NS).
Spontaneous AF was no longer observed during the stepwise increase in
atrial pressure after Gd3+ was added.
Effect of Verapamil on Vulnerability to AF
In 5 hearts, the effect of specific L-type calcium channel block
was studied with verapamil. Pacing thresholds were not
affected by verapamil (0.21±0.04 versus 0.20±0.03 mA at
baseline). Verapamil 1 µmol/L did not inhibit AF
induction during acute dilatation. P50 was
6.3±0.1 cm H2O at baseline and 4.9±0.2
cm H2O after application of
verapamil (P=NS). In the same preparations,
Gd3+ 50 µmol/L increased
P50 to 12.9±0.5 cm H2O
(P<0.001).
Atrial Refractoriness
The right atrial ERP progressively shortened with an increase in
atrial pressure (Figure 6
). On average,
ERP shifted from 78±3 ms at 0.5 cm H2O to 52±3
ms at 20 cm H2O (P<0.05). After
application of 50 µmol/L Gd3+, this
ERP-pressure relationship was maintained. ERP decreased from 73±3 ms
at 0.5 cm H2O to 54±2 ms at 20
cm H2O. At each pressure step, ERP was unchanged
from baseline (Figure 6
).
|
| Discussion |
|---|
|
|
|---|
Atrial enlargement is frequently observed in patients with AF.2 Atrial dilatation could develop as a result of the arrhythmia itself.18 Yet AF is also frequently associated with elevated intracavitary pressure and cardiac disorders that favor this condition.1 Numerous studies have demonstrated that the vulnerability to arrhythmias increases with myocardial stretch. For intact canine and rabbit atria, it has been shown that acute dilatation promotes tachyarrhythmic responses to burst pacing or single extrastimuli.8 9 19 Our study confirmed these findings. A fibrillatory response to electrical stimulation could be elicited only when atrial myocardium was preconditioned by stretch. Moreover, the degree of atrial dilatation influenced the duration of induced AF. The susceptibility to develop sustained AF increased with progressively higher pressure levels. The most widely accepted theory of the mechanism of AF suggests multiple wave fronts that wander through the atria and create continuous electrical activity.20 According to this hypothesis, progressive atrial dilatation must have changed atrial electrical properties in favor of the coexistence of multiple wavelets and their ability to continually encounter excitable tissue.
Electrical Changes Underlying AF Vulnerability
Acute stretch might contribute to arrhythmogenesis by several
mechanisms. In isolated cardiac tissue, mechanical stretch decreased
resting membrane potential and reduced action potential amplitude and
upstroke velocity.21 In whole-heart preparations and in
situ hearts, ventricular stretch decreased APD, thereby
shortening myocardial refractoriness.3 4 For the intact
atrium, conflicting data exist. In vivo studies investigated the
influence of rather modest alterations in atrial pressure due to
changes in paced AV intervals22 23 or infusion of plasma
expander.24 Refractory periods were reported by 1 group to
lengthen in response to an increase in atrial pressure,22
whereas others found either no effect on ERP24 or ERP
shortening.23 Isolated heart preparations exposed to
defined degrees of atrial stretch showed shortening of refractoriness
with increased atrial pressure, paralleled by an increase in AF
vulnerability.8 9 It has been postulated that ERP
shortening implies shortening of excitation wavelength and thereby
favors reentrant activity, which is generally recognized to entertain
AF.10 The high correlation between ERP shortening and AF
inducibility in the recent study by Ravelli and Allessie8
supports this hypothesis. Our data confirm previous results by
demonstrating a decrease in ERP and increased AF with progressive
atrial stretch. Yet we found the local atrial ERP response unaltered
after application of Gd3+, whereas the
vulnerability to AF was significantly reduced. Overall shortening of
ERP might therefore not fully explain the increased susceptibility to
AF during stretch. Evidence has been provided that acute atrial
dilatation increases the spatial dispersion of atrial
refractoriness.25 The inhomogeneous structure
of the atria can create regional differences in wall stress during
elevated intra-atrial pressure. Nonuniform distribution of local atrial
refractory periods due to heterogeneous wall stress could
establish a basis for the initiation and maintenance of atrial
reentry during stretch.25 SAC block by
Gd3+ might interfere with local electrical
properties dependent on the magnitude of regional wall stress and
possibly reduce ERP dispersion. This has to be further elucidated.
The wavelength of the atrial impulse is also determined by myocardial conduction properties. To date, the effect of acute myocardial stretch on intra-atrial conduction time has not been systematically evaluated. Studies performed in ventricular preparations reported no effects on conduction velocity within a physiological range of dilatation, whereas stretch beyond the optimal fiber length decreased conduction velocity.21 Alterations in conduction time depending on atrial load could influence the susceptibility to atrial reentry. If SACs mediate stretch-dependent changes in atrial conduction time, SAC block by Gd3+ can be expected to mitigate them.
In some of our experiments, the increased atrial irritability during stretch manifested in spontaneous onset of AF. A rise in atrial pressure elicited nonsustained runs of AF initiated by premature depolarizations. This is in accordance with previous observations in dog hearts that developed spontaneous atrial arrhythmias on atrial balloon dilatation.9 A possible explanation for premature depolarizations is the occurrence of afterdepolarizations. Sustained myocardial stretch induced afterdepolarizations in atrial tissue.14 Afterdepolarizations provoked by cesium chloride have recently been reported to account for onset of polymorphic atrial tachycardia degenerating into AF.26
Role of SACs
The presence of SACs capable of generating both inward and outward
currents might explain how stretch influences cardiac electrophysiology
and increases vulnerability to arrhythmia and cardiac
automaticity. Various types of SACs have been identified in cardiac
myocytes of different species, including rabbits and
humans.11 12 13 The most commonly reported type of SAC
nonselectively passes Ca2+ as well as monovalent
Na+ and K+ ions, whereas
other SACs are K+ or Cl-
selective.11 12 Reversal potentials of SACs range between
10 and -70 mV.11 Opening of SACs that do not show fatigue
during sustained stretch may account for repolarizing currents during
electrical systole that shorten APD and refractoriness. During
electrical diastole, SAC opening could establish
depolarizing currents that lead to afterdepolarizations. Intracellular
Ca2+ overload due to SAC opening may also account
for abbreviation of the action potential and production of
afterdepolarizations.27 An increase in
[Ca2+]i evolves when
heart cells are stretched.28
Effect of SAC Blockade
In single myocardial cells, Gd3+ has proved
to be a potent blocker of SACs that carry monovalent and divalent
cations.11 Gd3+ has also been shown
to reduce [Ca2+]i during
stretch.28 To date, only a few studies have focused on the
effect of SAC blockade in multicellular preparations.
Gd3+ suppressed stretch-induced depolarizations
in isolated canine ventricles when brief stretch was applied during
electrical diastole.6 The role of SACs during
sustained stretch has been studied in the working rat heart. Occurrence
of ventricular premature beats due to increased left
ventricular pressure was reduced by streptomycin, another
compound known to block SACs.29 Afterdepolarizations
produced by constant stretch in atrial tissue were suppressed by
Gd3+.14 SAC blockade by
Gd3+ was also reported to inhibit the release of
atrial natriuretic peptide,17 a substance that
might contribute to action potential shortening during atrial
stretch.30
Our study provides initial evidence that the propensity to AF during acute stretch can be modulated pharmacologically by a SAC-blocking agent. Gd3+ impeded electrical initiation of AF, hampered maintenance of burst-induced AF, and suppressed the generation of spontaneous AF during stretch. Although interference with myocardial propagation and/or repolarization properties during stretch appears to be crucial for the reduced ability to sustain AF, the absence of spontaneous AF after Gd3+ may be explained by suppression of afterdepolarizations and triggered activity.
Gadolinium, a potent blocker of SACs, is a nonspecific ion channel blocker. In single myocardial cells, voltage-clamp studies provided evidence for block of L-type Ca2+ channels with Gd3+ concentrations as low as 10 µmol/L.15 Block of IKR31 and sodium currents32 required up to 100 µmol/L Gd3+. Inhibitory concentrations have been shown to vary between isolated cells and intact tissue or among species.14 We cannot exclude the possibility that part of the effect of Gd3+ on the inducibility of AF during stretch was mediated by its calcium, potassium, and sodium channel blocking effects. Yet calcium channel block, perhaps the most prominent nonspecific Gd3+ effect, did not affect the vulnerability to AF in our study. This finding is in accordance with the failure of specific calcium channel blockers to suppress stretch-induced afterdepolarizations in isolated atrial tissue14 and arrhythmogenic responses in ventricular myocardium,6 whereas Gd3+ achieved suppression in these systems. If the effect of Gd3+ on AF vulnerability had been mediated by block of IKR, the ERP would have been expected to increase during Gd3+ application. The lack of ERP prolongation suggests that IKR block is not responsible for the effects we have observed with Gd3+. This evidence links the inhibitory effect of Gd3+ to a different mode of action, namely to its SAC-blocking properties.
Limitations
Manifestation of AF in this rabbit heart model cannot be
translated directly into the clinical manifestation of AF in patients.
The present study evaluated AF of short duration (>2
seconds) compared with long-lasting AF episodes that can be observed in
patients. Definitions of AF duration in this model were based on the
low tendency of the rabbit atrium to fibrillate. This was emphasized by
the inability to induce AF in the undilated atrium and the prompt
termination of stretch-facilitated AF by return of atrial pressure to
normal levels. The small size of rabbit atria does not provide
sufficient tissue mass to entertain multiwavelet reentrant activity.
Unlike in the larger human atria, perpetuation of AF has to be promoted
by interventions that shorten wavelength10 or increase
atrial surface area. Therefore, we assumed that even brief episodes of
AF in rabbit atria can reflect a considerable increase in AF
vulnerability.
Conclusions
Our study showed that the SAC blocker Gd3+
modulated the electrophysiological
properties of the intact rabbit atrium during acute dilatation. A
decrease in the stretch-induced vulnerability to AF was
consistent with the concept that the facilitation of AF may be
mediated by SACs. Thus, SAC block with such agents as
Gd3+ may represent a novel antiarrhythmic
approach to diminish the proarrhythmic effect of acute atrial stretch
on AF.
| Acknowledgments |
|---|
Received June 11, 1999; revision received November 22, 1999; accepted December 12, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
I. Savelieva and J. Camm Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches Europace, June 1, 2008; 10(6): 647 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. L. Kuijpers, H. M. M. ten Eikelder, P. H. M. Bovendeerd, S. Verheule, T. Arts, and P. A. J. Hilbers Mechanoelectric feedback leads to conduction slowing and block in acutely dilated atria: a modeling study of cardiac electromechanics Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2832 - H2853. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Ninio and D. A. Saint Passive pericardial constraint protects against stretch-induced vulnerability to atrial fibrillation in rabbits Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2547 - H2549. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. McNicholas-Bevensee, K. B. DeAndrade, W. E. Bradley, L. J. Dell'Italia, P. A. Lucchesi, and M. O. Bevensee Activation of gadolinium-sensitive ion channels in cardiomyocytes in early adaptive stages of volume overload-induced heart failure Cardiovasc Res, November 1, 2006; 72(2): 262 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lofberg, I. Jacobson, and L. Carlsson Electrophysiological and antiarrhythmic effects of the novel antiarrhythmic agent AZD7009: a comparison with azimilide and AVE0118 in the acutely dilated right atrium of the rabbit in vitro Europace, July 1, 2006; 8(7): 549 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Barrabes, D. Garcia-Dorado, L. Agullo, A. Rodriguez-Sinovas, F. Padilla, L. Trobo, and J. Soler-Soler Intracoronary infusion of Gd3+ into ischemic region does not suppress phase Ib ventricular arrhythmias after coronary occlusion in swine Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2344 - H2350. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Reant, S. Lafitte, P. Jais, K. Serri, R. Weerasooriya, M. Hocini, X. Pillois, J. Clementy, M. Haissaguerre, and R. Roudaut Reverse Remodeling of the Left Cardiac Chambers After Catheter Ablation After 1 Year in a Series of Patients With Isolated Atrial Fibrillation Circulation, November 8, 2005; 112(19): 2896 - 2903. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Gersh, T. S.M. Tsang, M. E. Barnes, and J. B. Seward The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C5 - C11. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verheule, E. Wilson, S. Banthia, T. H. Everett IV, S. Shanbhag, H. J. Sih, and J. Olgin Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H634 - H644. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Cha, M. M. Redfield, W.-K. Shen, and B. J. Gersh Atrial Fibrillation and Ventricular Dysfunction: A Vicious Electromechanical Cycle Circulation, June 15, 2004; 109(23): 2839 - 2843. [Full Text] [PDF] |
||||
![]() |
J. Kalifa, J. Jalife, A. V. Zaitsev, S. Bagwe, M. Warren, J. Moreno, O. Berenfeld, and S. Nattel Intra-Atrial Pressure Increases Rate and Organization of Waves Emanating From the Superior Pulmonary Veins During Atrial Fibrillation Circulation, August 12, 2003; 108(6): 668 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verheule, E. Wilson, T. Everett IV, S. Shanbhag, C. Golden, and J. Olgin Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation Circulation, May 27, 2003; 107(20): 2615 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kanagala, N. S. Murali, P. A. Friedman, N. M. Ammash, B. J. Gersh, K. V. Ballman, A. S. M. Shamsuzzaman, and V. K. Somers Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation Circulation, May 27, 2003; 107(20): 2589 - 2594. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Savelieva and A. John Camm Atrial fibrillation and heart failure: natural history and pharmacological treatment Europace, January 1, 2003; 5(s1): S5 - S19. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Nicolosi, G. West, J. G. Markley, B. Logan, and G. N. Olinger Gadolinium attenuates regional stunning in the canine heart in vivo J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 57 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinagawa, Y.-F. Shi, J.-C. Tardif, T.-K. Leung, and S. Nattel Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs Circulation, June 4, 2002; 105(22): 2672 - 2678. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F Bosch and S. Nattel Cellular electrophysiology of atrial fibrillation Cardiovasc Res, May 1, 2002; 54(2): 259 - 269. [Full Text] [PDF] |
||||
![]() |
A.J. Camm Future role of electrical therapy for atrial fibrillation: reality for all? Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P53 - P56. [Abstract] [PDF] |
||||
![]() |
Y. Shi, A. Ducharme, D. Li, R. Gaspo, S. Nattel, and J.-C. Tardif Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation Cardiovasc Res, November 1, 2001; 52(2): 217 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Nicolosi, C. S. Kwok, S. J. Contney, G. N. Olinger, and Z. J. Bosnjak Gadolinium prevents stretch-mediated contractile dysfunction in isolated papillary muscles Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1122 - H1128. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||